Home › Multiple Myeloma › New Jersey › Newark
Multiple Myeloma clinical trials in Newark, NJ
3 studies for Multiple Myeloma are looking for participants at sites in and around Newark (within about 30 miles). Open a study to see who can join and how to contact the study team.
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RecruitingPhase 3
- Carol G Simon Cancer Center, Morristown · 17 mi away
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RecruitingPhase 3
- Atlantic Health System Morristown Medical Center, Morristown · 17 mi away
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecruitingPhase 1/2
- Atlantic Health, Morristown · 17 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Rochester, MN24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- St. Louis, MO23 studies
- Washington, DC22 studies
Other studies in Newark
- Breast Cancer18 studies
- Non-Small Cell Lung Cancer14 studies
- Spinal Cord Injuries13 studies
- Acute Myeloid Leukemia12 studies
- Metastatic Cancer10 studies
- Heart Failure10 studies
- Pancreatic Cancer9 studies
- Cardiovascular Disease9 studies
- Cancer (all types)8 studies
- Melanoma8 studies
- Crohn's Disease7 studies
- Lung Cancer7 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.